BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12238)

  • 1. [Plasma cyclic AMP level and cAMP phosphodiesterase activity in Takayasu's disease (author's transl)].
    Nlmano F; Kochi K; Arita M; Tamaki H; Numano F
    Nihon Naika Gakkai Zasshi; 1976 Oct; 65(10):1020-5. PubMed ID: 12238
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperaggregability of platelets in thromboembolic disorders.
    Yamazaki H; Sano T; Asano T; Hidaka H
    Thromb Res; 1976 May; 8(2 suppl):217-25. PubMed ID: 7029
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte cyclic-3', 5'-nucleotide phosphodiesterase activity in human bronchial asthma.
    Mue S; Ise T; Shibahara S; Takahashi M; Ono Y
    Ann Allergy; 1976 Sep; 37(3):201-7. PubMed ID: 183572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cAMP and cAMP-phosphodiesterase (PDE) levels in cancer patients before and after surgery.
    Patel V; Banu N; Malhotra OP; Udupa KN
    Indian J Cancer; 1981 Sep; 18(3):181-4. PubMed ID: 6273301
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes.
    Scher NS; Quagliata F; Malathi VG; Faig D; Melton RA; Silber R
    Cancer Res; 1976 Nov; 36(11 Pt 1):3958-62. PubMed ID: 184920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of guanosine and adenosine 3',5'-monophosphates by rat blood.
    Patterson WD; Hardman JG; Sutherland EW
    Biochim Biophys Acta; 1975 Mar; 384(1):159-67. PubMed ID: 165831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA antigens in Takayasu's disease (author's transl)].
    Numano F; Isohisa I; Maezawa H
    Nihon Naika Gakkai Zasshi; 1978 Mar; 67(3):258-66. PubMed ID: 26725
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma c-AMP and c-AMP-PDE activity in carcinoma of uterine cervix.
    Singh RP; Shukla M; Singh VP; Udupa KN
    Mater Med Pol; 1988; 20(2):76-8. PubMed ID: 2851690
    [No Abstract]   [Full Text] [Related]  

  • 9. [The seasonal rhythm of changes in adenosine cyclic monophosphate phosphodiesterase activity in the lymphocytes of human peripheral blood].
    Kochetkova MN; Ozeretskovskaia NN; Ezhkova NG
    Izv Akad Nauk SSSR Biol; 1988; (5):782-5. PubMed ID: 2849615
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction.
    Kurokawa Y; Fukuda I; Mozai T
    Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
    Tremblay J; Lachance B; Hamet P
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the plasma levels of thromboxane B2 and cyclic nucleotides in patients with Takayasu disease.
    Numano F; Shimokado K; Kishi Y; Nishiyama K; Türkoglu C; Yajima M; Numano F; Maezawa H
    Jpn Circ J; 1982 Jan; 46(1):16-20. PubMed ID: 6119373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
    J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the hydrolytic activity, inhibitor sensitivity and molecular size of the rat erythrocyte cyclic AMP phosphodiesterase by calcium and hypertonic sodium chloride.
    Sheppard H; Tsien WH
    J Cyclic Nucleotide Res; 1975; 1(4):237-42. PubMed ID: 177464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changed phosphodiesterase activity of leukocytes in atopic eczema].
    Hanifin JM
    Hautarzt; 1987 May; 38(5):258-61. PubMed ID: 3038785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension and Takayasu's disease (author's transl)].
    Lagneau P
    J Mal Vasc; 1982; 7(1):21-4. PubMed ID: 6122705
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aneurysmal dilatation in Takayasu's arteritis--especialy, the long-term results of surgical and non-surgical treatment (author's transl)].
    Fukushima K
    Nihon Kyobu Geka Gakkai Zasshi; 1977 Dec; 25(12):1622-42. PubMed ID: 25936
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes.
    Hait WN; Weiss B
    Biochim Biophys Acta; 1977 Mar; 497(1):86-100. PubMed ID: 14711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
    Wang TY; Hussey CV; Sasse EA; Fobian JE
    Ann Clin Lab Sci; 1978; 8(5):403-12. PubMed ID: 213009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.